Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Pediatría | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Study Of Nifurtimox Transfer Into Breastmilk In Lactating Women With Chagas Disease
OBSERVATIONAL
Inicio: 1 de dic de 2012
ID: NCT01744405
Reclutando
Fase 3
ClinicalTrials.gov
A Phase III, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Pharmacokinetics, Pharmacodynamics, Efficacy, and Safety of IV Anifrolumab in Pediatric Participants 5 to < 18 Years of Age With Moderate to Severe Active Systemic Lupus Erythematosus While on Background Standard of Care Therapy
INTERVENTIONAL
Inicio: 14 de mar de 2024
ID: NCT05835310
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Multicenter, Multinational, Phase 3B, Open-Label, Parallel-Group Study of Fabrazyme (Agalsidase Beta) in Treatment-Naïve Male Pediatric Patients With Fabry Disease Without Severe Symptoms
INTERVENTIONAL
Inicio: 1 de sept de 2008
ID: NCT00701415
Completado
ClinicalTrials.gov
Easypod Connect: A National, Multicentre, Observational Registry to Evaluate Adherence and Long Term Outcomes of Therapy in Paediatric Subjects Using "Easypod™" Electromechanical Device for Growth Hormone Treatment in Argentina
OBSERVATIONAL
Inicio: 31 de mar de 2013
ID: NCT01582334
Completado
Fase 2
ClinicalTrials.gov
A Phase I/II, Multicenter, Open-Label, Noncomparative Study of the International Maternal, Pediatric, Adolescent AIDS Clinical Trials (IMPAACT) Group to Evaluate the Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of Raltegravir (Isentress, MK-0518) in HIV-1 Infected Children and Adolescents
INTERVENTIONAL
Inicio: 17 de sept de 2007
ID: NCT00485264
Completado
Fase 2
ClinicalTrials.gov
A 3-part Open-label Study to Assess the Pharmacokinetics of Lanthanum Carbonate, Compare the Efficacy, Safety and Tolerability of 8 Weeks of Treatment With Lanthanum Carbonate and Calcium Carbonate Using a Crossover Design and Investigate the Efficacy and Safety of 8 Months of Treatment With Lanthanum Carbonate in Hyperphosphataemic Children and Adolescents Aged 10 Years to <18 Years With Chronic Kidney Disease on Dialysis
INTERVENTIONAL
Inicio: 15 de feb de 2013
ID: NCT01696279
Terminado
Fase 4
ClinicalTrials.gov
Evaluation of 3TC or FTC Mono-therapy Compared to Continuing HAART as a Bridging Antiretroviral Strategy in Persistently Non-adherent Children, Adolescents, and Young Adults Who Are Failing HAART and Have the M184V Resistance Mutation.
INTERVENTIONAL
Inicio: 1 de mar de 2011
ID: NCT01338025
Terminado
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Double-blind, Placebo-controlled, Multi-center Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-care Treatment in Adolescent, Adult, and Elderly Non-hospitalized Subjects With Influenza A Infection Who Are at Risk of Developing Complications
INTERVENTIONAL
Inicio: 21 de ene de 2018
ID: NCT03381196
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open-label, Randomized, Multicenter, 12 Months, Efficacy and Safety Study of Weekly MOD-4023 Compared to Daily Genotropin - Therapy in Pre-pubertal Children With Growth Hormone Deficiency
INTERVENTIONAL
Inicio: 1 de dic de 2016
ID: NCT02968004
Retirado
Fase 4
ClinicalTrials.gov
Topical Morphine for Analgesia in Pediatric Procedures. Clinical Trial Randomized, Double-blind, Placebo.
INTERVENTIONAL
Inicio: 1 de dic de 2014
ID: NCT02300194
Reclutando
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase 3 Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Deucravacitinib in Adolescent Participants (12 Years to Less Than 18 Years) With Moderate to Severe Plaque Psoriasis
INTERVENTIONAL
Inicio: 3 de dic de 2025
ID: NCT06979453
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3, Multicenter, Double-blind Maintenance Study to Assess Long-term Safety, Tolerability, and Efficacy of Rocatinlimab in Adult and Adolescent Subjects With Moderate-to-severe Atopic Dermatitis (AD) (ROCKET-ASCEND)
INTERVENTIONAL
Inicio: 31 de may de 2023
ID: NCT05882877
Completado
Fase 3
ClinicalTrials.gov
A Multicenter, Randomized, Observer-Blinded, Active-Controlled Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of Ceftaroline Versus Comparator in Pediatric Subjects With Acute Bacterial Skin and Skin Structure Infections
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01400867
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Open Label Study Comparing Safety and Efficacy Parameters for a High and a Low Dose of Ambrisentan (Adjusted for Body Weight) for the Treatment of Pulmonary Arterial Hypertension in Paediatric Patients Aged 8 Years up to 18 Years
INTERVENTIONAL
Inicio: 4 de ene de 2011
ID: NCT01332331
Terminado
Fase 3
ClinicalTrials.gov
A Multicenter, Multinational, Randomized, Double-blind, Placebo-controlled Study to Assess the Efficacy, Pharmacodynamics, Pharmacokinetics, Safety, and Tolerability of Venglustat in Late-onset GM2 Gangliosidosis (Tay-Sachs Disease and Sandhoff Disease) Together With a Separate Basket for Juvenile/Adolescent Late-onset GM2 Gangliosidosis and Ultra-rare Diseases Within the Same and Similar Glucosylceramide-based Sphingolipid Pathway
INTERVENTIONAL
Inicio: 29 de jun de 2020
ID: NCT04221451
Completado
Fase 3
ClinicalTrials.gov
A Phase 3 Multi-center, Open-Label Study to Evaluate Pharmacokinetics, Efficacy and Safety of Abatacept Administered Subcutaneously (SC) in Children and Adolescents With Active Polyarticular Juvenile Idiopathic Arthritis (pJIA) and Inadequate Response (IR) to Biologic or Non Biologic Disease Modifying Anti-rheumatic Drugs (DMARDs)
INTERVENTIONAL
Inicio: 30 de ago de 2013
ID: NCT01844518
Anterior
1
...
26
27
28
...
434
Siguiente
Filtros